Bygdeman M - Search Results

1

Intracervical versus intravaginal PGE2 for induction of labor at term in patients with an unfavorable cervix.

Ulmsten U, Ekman G, Belfrage P, Bygdeman M, Nyberg C. Ulmsten U, et al. Among authors: bygdeman m. Arch Gynecol. 1985;236(4):243-8. doi: 10.1007/BF02133942. Arch Gynecol. 1985. PMID: 3861138 Clinical Trial.

2

A new prostaglandin E2-gel for pretreatment of the cervix in nulliparous patients having a late first trimester termination of pregnancy.

Wingerup L, Ulmsten U, Bygdeman M, Ekman G, Hamberger L, Lundström V, Norström A. Wingerup L, et al. Among authors: bygdeman m. Arch Gynecol. 1981;231(1):1-6. doi: 10.1007/BF02110018. Arch Gynecol. 1981. PMID: 6949498

3

Experience with an industrially manufactured gel PGE2 for cervical priming.

Floberg J, Allen J, Belfrage P, Bygdeman M, Ulmsten U. Floberg J, et al. Among authors: bygdeman m. Arch Gynecol. 1983;233(3):225-8. doi: 10.1007/BF02114604. Arch Gynecol. 1983. PMID: 6625668

4

Induction of labor with mifepristone--a randomized, double-blind study versus placebo.

Stenlund PM, Ekman G, Aedo AR, Bygdeman M. Stenlund PM, et al. Among authors: bygdeman m. Acta Obstet Gynecol Scand. 1999 Oct;78(9):793-8. Acta Obstet Gynecol Scand. 1999. PMID: 10535343 Clinical Trial.

5

Bioconversion of arachidonic acid in human pregnant uterine cervix.

Christensen NJ, Belfrage P, Bygdeman M, Floberg J, Miszuhashi N, Gréen K. Christensen NJ, et al. Among authors: bygdeman m. Acta Obstet Gynecol Scand. 1985;64(3):259-65. doi: 10.3109/00016348509155125. Acta Obstet Gynecol Scand. 1985. PMID: 4013692

6

Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.

Moberg PJ, Bygdeman M, Carnsjö LG, Frankman O, Gréen K. Moberg PJ, et al. Among authors: bygdeman m. Acta Obstet Gynecol Scand Suppl. 1983;113:137-40. doi: 10.3109/00016348309155215. Acta Obstet Gynecol Scand Suppl. 1983. PMID: 6574668

7

Dilatation of the cervix prior to vacuum aspiration by single vaginal administration of 15-methyl-PGF2 alpha methyl ester.

Frankman O, Bygdeman M, Gréen K, Moberg P, Sandberg CG. Frankman O, et al. Among authors: bygdeman m. Contraception. 1980 Jun;21(6):571-6. doi: 10.1016/0010-7824(80)90030-x. Contraception. 1980. PMID: 7428365

8

Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.

Gréen K, Bygdeman M, Swahn ML, Vesterqvist O, Christensen NJ. Gréen K, et al. Among authors: bygdeman m. Prostaglandins Leukot Essent Fatty Acids. 1988 Aug;33(2):121-7. doi: 10.1016/0952-3278(88)90151-2. Prostaglandins Leukot Essent Fatty Acids. 1988. PMID: 3174718

9

[Induction of labor with prostaglandins].

Bygdeman M, Wiqvist N. Bygdeman M, et al. Lakartidningen. 1975 Jan 15;72(3):136-7. Lakartidningen. 1975. PMID: 1123944 Swedish. No abstract available.

10

Termination of second-trimester pregnancy by laminaria and intramuscular injections of 15-methyl PGF2 alpha or 16-phenoxy-omega-17,18,19, 20-tetranor PGE2 methyl sulfonylamide. A randomized study.

Bygdeman M, Christensen NJ. Bygdeman M, et al. Acta Obstet Gynecol Scand. 1983;62(5):535-7. doi: 10.3109/00016348309154232. Acta Obstet Gynecol Scand. 1983. PMID: 6364688 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page